Compounds which are 3-arylsulfonyl-2-methyl propanoic acid derivatives of formula (I): wherein X is HO—NH— or HO—, R1 is selected from phenyl, 4-chlorophenyl, 4-florophenyl, 4-cyanophenyl, benzamido (i.e., —NH—CO-Ph) and benzamido substituted on the terminal phenyl ring by C1-C4 alkyl, fluoro, chloro, cyano or C1-4 alkoxy; R2 is selected from (a) —S—Ar or —S—CH2—Ar wherein Ar is an aromatic moiety; (b) —O—Ar wherein Ar is as defined above; (c) —S-Het or —S—CH2-Het wherein Het is a heterocyclic ring; and (d) 2,5-dioxo-1-imidazolidinyl or 2,4-dioxo-1-imidazolinyl; and the pharmaceutically acceptable salts thereof; have potent and selective inhibitory activity against matrix metalloproteinases (MMPs) and can thus be used in the treatment and prevention of diseases mediated by MMPs.
化合物是公式(I)的3-芳基磺酰基-2-
甲基丙烯酸衍
生物,其中X为HO—NH—或HO—,R1从苯基、4-
氯苯基、4-
氟苯基、4-
氰苯基、苯甲酰
氨基(即,—NH—CO-Ph)和苯甲酰
氨基中选择,其在末端苯环上被C1-C4烷基、
氟、
氯、
氰或C1-4烷氧基取代;R2从(a) —S—Ar或—S—
CH2—Ar中选择,其中Ar是芳香基;(b) —O—Ar,其中Ar如上所定义;(c) —S-Het或—S— -Het,其中Het是杂环环;和(d) 2,5-二氧杂-1-
咪唑烷基或2,4-二氧杂-1-
咪唑烷基;以及其药学上可接受的盐;具有对基质
金属
蛋白酶(MMPs)具有强效和选择性抑制活性,因此可用于治疗和预防由MMPs介导的疾病。